Long-term Cardiovascular Impact of COVID-19: A Review of 71 Studies

A narrative synthesis review of 71 studies published between December 2019 and January 2024 on long-term cardiovascular outcomes of COVID-19. The review, authored by Nutan Maurya, compares hospitalised and non-hospitalised patients, finding persistent cardiac dysfunction across both groups. Studies were sourced from PubMed, MEDLINE, CINAHL, and Embase, with most being observational and conducted in Europe and Asia.

Use Cases

• Comparing cardiovascular complication rates between hospitalised and non-hospitalised COVID-19 patients based on the review's findings.
• Identifying common long-term cardiovascular symptoms like palpitations, chest pain, and fatigue described in the synthesis.
• Assessing the reported protective effect of vaccination against long-term cardiovascular risks.
• Evaluating the heterogeneity in study designs and symptom reporting across the 71 included observational studies.

Strengths

• Synthesizes evidence from 71 distinct studies.
• Explicitly compares outcomes for hospitalised and non-hospitalised patient groups.
• Covers a defined publication time range from December 2019 to January 2024.
• Released under a permissive CC-BY-4.0 license.

Limitations

• The dataset is a 21.4 KB document, indicating a limited scope of raw data.
• Row and column structures are unknown; the content is a narrative review.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

figshare, author Nutan Maurya.

Collection Method

Narrative synthesis of studies from PubMed, MEDLINE, CINAHL, and Embase.

Time Range

Studies published between December 2019 and January 2024.

Freshness

Last updated 2026-05-07 05:42:56; freshness should be verified.

Geography

Studies were primarily conducted in Europe and Asia.